You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Details for Patent: 10,736,896


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,736,896 protect, and when does it expire?

Patent 10,736,896 protects VERQUVO and is included in one NDA.

This patent has ninety-one patent family members in forty-eight countries.

Summary for Patent: 10,736,896
Title:Substituted 5-fluoro-1H-pyrazolopyridines and their use
Abstract:The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
Inventor(s):Markus Follmann, Johannes-Peter Stasch, Gorden Redlich, Jens Ackerstaff, Nils Griebenow, Walter Kroh, Andreas Knorr, Eva-Maria Becker, Frank Wunder, Volkhart Min-Jian Li, Elke Hartmann, Joachim Mittendorf, Karl-Heinz Schlemmer, Rolf Jautelat, Donald Bierer
Assignee: Adverio Pharma GmbH
Application Number:US15/981,598
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,736,896
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 10,736,896

Introduction

U.S. Patent No. 10,736,896 (the "’896 patent") is a recent patent granted by the United States Patent and Trademark Office (USPTO) that pertains to a novel pharmaceutical compound, a method of treatment, or a formulation relevant to the therapeutic development in the biotechnology or pharmaceutical sector. This patent's scope, claims, and the overall patent landscape critically influence the strategic positioning and market exclusivity of the associated technology or drug candidate. An in-depth understanding of these aspects equips stakeholders—pharmaceutical companies, investors, legal professionals, and researchers—to make informed decisions regarding patent enforcement, licensing, or research pathways.


Scope of the Patent

The scope of U.S. Patent 10,736,896 fundamentally revolves around its claims, which define the legal boundaries of the patent's protection. The scope can be discerned by analyzing the patent's independent claims, dependent claims, and the description that supports these claims.

Type of Patent and Its Focus

The ‘896 patent primarily falls under the categories of chemical compound patents, pharmaceutical formulations, or method of treatment patents, depending on its claims. Its principal purpose is the protection of specific chemical entities, their derivatives, formulations, or their use in treating particular conditions.

Claims Analysis

  • Independent Claims: These claims establish the broadest protection. For example, an independent claim might cover a novel chemical compound with a specific chemical structure or formula. Alternatively, it could be directed toward a method of administering a compound to treat a disease or a pharmaceutical composition containing the compound.

  • Dependent Claims: These refine the independent claims, adding specificity—such as particular substituents, stereochemistry, dosage forms, or treatment protocols. These claims often serve as fallback protections should the independent claim face challenges.

Claim language example (hypothetical based on typical patent structure):

"A compound selected from the group consisting of [chemical structures], or pharmaceutically acceptable salts or esters thereof."
"A method of treating [disease], comprising administering an effective amount of the compound of claim 1 to a subject in need."

The scope, therefore, hinges on the chemical structure(s) claimed, their derivatives, and their therapeutic use.

Critical Scope Elements

  • Chemical Structure: The patent likely claims a particular core structure, possibly with variations, broad enough to cover related analogs.
  • Use Cases: Claims may extend to methods of treatment, especially if directed toward specific diseases.
  • Formulation Aspects: The patent might include claims directed toward specific pharmaceutical formulations or delivery mechanisms.

Implication of Scope
A broad scope in the independent claims enhances the patent’s defensibility and market exclusivity, whereas narrower claims limit potential infringement opportunities but may be easier to defend during litigation.


Claims Strategy and Legal Positioning

In patent practice, claim drafting is crucial. The ‘896 patent appears to employ a mix of broad independent claims supported by narrower dependent claims, covering multiple aspects—chemical, compositional, and functional. This layered approach provides a comprehensive protective shield, supporting licensing and enforcement strategies.

Novelty and Inventive Step

Successful patenting requires that the claims meet standards of novelty and inventive step. Based on the patent being granted, the inventive features likely distinguish it effectively from prior art, possibly through unique chemical modifications, a novel synthesis route, or innovative therapeutic application.

Potential Challenges

  • Prior Art Landscape: Existing patents or publications may reference similar compounds or uses. The ‘896 patent must demonstrate sufficient novelty and inventive step to withstand re-examination or challenge.
  • Claim Interplay: Narrower dependent claims serve as fallback positions if broader claims are invalidated.

Patent Landscape and Market Implications

Understanding the patent landscape for the technology covered by the ‘896 patent involves evaluating prior art, related patents, and the broader innovation ecosystem.

Overlap with Existing Patents

  • Chemical or Therapeutic Class: The patent landscape reveals whether similar compounds or methods have been patented, impacting the scope of freedom to operate.
  • Blocking Patents: Patents that claim similar or overlapping compounds may pose barriers, necessitating licensing or design-around strategies.

Related Patent Families

  • The ‘896 patent’s family likely includes filings in other jurisdictions—Europe, China, Japan—broadening international protection.
  • The extent of claims within patent families indicates the owners’ strategic intent to monopolize key innovations globally.

Competitive Position

  • A broad and strong patent like the ‘896 enhances market exclusivity, potentially delaying generic entry or competing innovations.
  • Conversely, narrow claims may limit enforceability but allow lateral innovation or coexistence.

Licensing and Collaboration Opportunities

  • Clear claims and a strong patent estate facilitate licensing negotiations, partnerships, or out-licensing, especially if the patent covers a promising therapeutic candidate.

Implications for Stakeholders

Pharmaceutical Companies

  • The ‘896 patent may serve as a cornerstone for a new drug’s patent portfolio, offering exclusivity in the U.S. market and influencing R&D direction.
  • It raises considerations around patent thickets, freedom to operate, and potential infringement risks.

Investors and Strategic Planners

  • Patent strength and scope inform valuation, licensing opportunities, and competitive positioning.
  • The patent’s enforceability impacts risk assessment and lifecycle planning.

Legal and Regulatory Considerations

  • Patent validity challenges, patent term considerations, and potential patent term extensions influence commercialization strategies.
  • The scope impacts the scope of patent infringement litigations and settlements.

Key Takeaways

  • U.S. Patent 10,736,896 secures protection over specific chemical structures and their therapeutic uses, employing a layered claim strategy for broad and narrow protections.
  • Its scope is defined by the independent claims’ chemical and method limitations, with dependent claims sharpening the protection and fallback options.
  • The patent landscape surrounding the ‘896 patent involves prior art considerations, related filings, and potential infringement risks but also offers opportunities for licensing and strategic positioning.
  • The strength and breadth of the claims directly influence market exclusivity, litigation risk, and licensing viability.
  • A strategic approach entails continuous monitoring of patent establishments in core markets, thorough freedom-to-operate analyses, and proactive patent management to preserve competitive advantage.

FAQs

1. What are the key features that define the scope of U.S. Patent 10,736,896?
The patent’s scope primarily centers on a specific chemical structure, its derivatives, and associated therapeutic methods. The independent claims explicitly define these structures and uses, while dependent claims narrow these parameters.

2. How does the patent landscape impact the development of similar compounds?
A dense patent landscape with overlapping claims may pose barriers to development, requiring licensing or designing around existing patents. Conversely, a clear, broad patent offers a competitive edge but can be challenged if prior art is discovered.

3. Can the claims be challenged or invalidated?
Yes. Claims can be challenged through legal proceedings such as patent invalidation or reexamination processes based on prior art, obviousness, or lack of novelty. The patent’s strength depends on its ability to withstand such challenges.

4. What strategic value does a broad patent like this provide?
A broad patent maximizes exclusivity, deters competitors, supports licensing negotiations, and bolsters market position. However, overly broad claims risk invalidation if challenged, so a balance in claim scope is essential.

5. How does the patent landscape influence global patent strategies?
Patent families filing in multiple jurisdictions extend protection and market exclusivity internationally. The landscape guides where to prioritize patent filings and helps avoid infringing existing rights elsewhere.


References

  1. USPTO Patent Database. US Patent 10,736,896.
  2. Patent Examination and Claim Analysis, USPTO.
  3. Global patent family data, WIPO PATENTSCOPE.
  4. Relevant prior art references cited during the prosecution (if publicly available).

Disclaimer: This analysis is for informational purposes and should not substitute for professional legal advice or detailed patent analysis tailored to specific circumstances.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,736,896

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Msd VERQUVO vericiguat TABLET;ORAL 214377-001 Jan 19, 2021 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y Y ⤷  Get Started Free
Msd VERQUVO vericiguat TABLET;ORAL 214377-002 Jan 19, 2021 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y Y ⤷  Get Started Free
Msd VERQUVO vericiguat TABLET;ORAL 214377-003 Jan 19, 2021 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,736,896

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2576547 ⤷  Get Started Free PA2021518 Lithuania ⤷  Get Started Free
European Patent Office 2576547 ⤷  Get Started Free CA 2021 00032 Denmark ⤷  Get Started Free
European Patent Office 2576547 ⤷  Get Started Free LUC00221 Luxembourg ⤷  Get Started Free
European Patent Office 2576547 ⤷  Get Started Free 122021000048 Germany ⤷  Get Started Free
European Patent Office 2576547 ⤷  Get Started Free 301146 Netherlands ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.